NrCAM is a marker for substrate-selective activation of ADAM10 in Alzheimer's disease. - Brummer, T.; Muller, S. A.; Pan-Montojo, F.; Yoshida, F.; Fellgiebel, A.; Tomita, T.; Endres, K.; Lichtenthaler, S. F. (EMBO Mol Med, 2019)